KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Medpace Holdings (MEDP) Leases (2016 - 2026)

Medpace Holdings filings provide 12 years of Leases readings, the most recent being $126.8 million for Q1 2026.

  • On a quarterly basis, Leases fell 2.35% to $126.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $126.8 million, a 2.35% decrease, with the full-year FY2025 number at $117.8 million, down 8.42% from a year prior.
  • Leases hit $126.8 million in Q1 2026 for Medpace Holdings, up from $117.8 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $144.8 million in Q4 2023 to a low of $117.8 million in Q4 2025.
  • Median Leases over the past 5 years was $135.4 million (2022), compared with a mean of $134.5 million.
  • Biggest five-year swings in Leases: rose 26.16% in 2022 and later fell 11.15% in 2024.
  • Medpace Holdings' Leases stood at $139.1 million in 2022, then increased by 4.12% to $144.8 million in 2023, then dropped by 11.15% to $128.6 million in 2024, then dropped by 8.42% to $117.8 million in 2025, then grew by 7.64% to $126.8 million in 2026.
  • The last three reported values for Leases were $126.8 million (Q1 2026), $117.8 million (Q4 2025), and $123.6 million (Q3 2025) per Business Quant data.